PMC · DOI:10.3389/fphar.2025.1700196·October 13, 2025
Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?
Rosmin Esmail, Nora Ibargoyen-Roteta, Maximilian Otte, Iñaki Gutiérrez-Ibarluzea, Roberta Joppi, Hans-Peter Dauben
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Genes1
Proteins1
Species1
Chemicals4
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare cost, quality, practices · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management